Oxidation of human apolipoprotein e and cerebral enzymatic systems

Alzheimer's Reports

Volumn 1, Issue 2, 1998, Pages 95-99

  Leininger Muller, Brigitte ^a   Jolivalt, Corinne ^a   Bertrand, Philippe ^a   Siest, Gérard ^a  

^a Centre du Medicament URA CNRS 597   (France)

Author keywords

Alzheimer's disease; Apolipoprotein e; Glutathione s transferase; Myeloperoxidase; Oxidation

Indexed keywords

EID: 22044441887     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aniya Y, Shigenaga MK and Hagen TM (1993). Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 90, 7915-7922.
2. Barbier A, Visvikis A, Mathieu F et al. (1997). Characterization of three human apolipoprotein E isoforms (E2, E3 and E4) expressed in Escherichia coli. Eur J Clin Chem Clin Biochem 35, 581-589.
3. Bertrand P, Shuvaev V, Leininger-Muller B et al. (1997). Apolipoprotein E interaction with amyloid-β: influence of apolipoprotein E association with phospholipids and heparin. Facts Res Geront 4, 470-472.
4. Ghersi-Egea JF, Livertoux MH, Minn A et al. (1991). Enzymemediated Superoxide radical formation initiated by exogenous molecules in rat brain preparations. Toxicol Appl Pharmacol 110, 107-117.
5. Ghersi-Egea JF, Perrin R, Leininger-Muller B et al. (1993). Sub-cellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45, 647-658.
6. Ghersi-Egea JF, Leininger-Muller B, Suleman G et al. (1994). Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62, 1089-1096.
7. Goldgaber D, Schwarzman Al, Bhasin R et al. (1993). Sequestration of amyloid β-peptide. Ann NY Acad Sci 695, 139-143.
8. Habig WH, Pabst MJ and Jakoby WB (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249, 7130-7139.
9. Jolivalt C, Leininger-Muller B, Drozdz R et al. (1996). Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci Lett 210, 61-64.
10. Jonas A (1984). A review of plasma apolipoprotein A-1 interaction with phosphatidylcholines Exp Lung Res 6, 255-270.
11. Leininger-Muller B, Ghersi-Egea JF, Siest G et al. (1994). Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett 175, 37-40.
12. Leininger-Muller B, Jolivalt C, Pillot T et al. (1996). Apolipoprotein E oxidation and functional consequences. In:Roses AD ed Apolipoprotein E and Alzheimer's Disease. Springer-Verlag, Berlin Heidelberg:161-169.
13. Leininger-Muller B, Jolivalt C, Bertrand P and Siest G (1998). Oxidation of human apolipoprotein E. In : Packer L, Christen Y eds. Ginkgo biloba extract (EGb 761) study: Lessons from cell biology. Advances in EGb 761 Research, Vol 7. Elsevier, Paris.
14. Listowsky I, Abramovitz M, Homma H and Niitsu Y (1988). Intracellular binding of hormones and xenobiotics by glutathione S-transferases. Drug Metab Rev 19, 305-318.
15. Lowry O.H, Rosebrough NJ, Farr AL and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
16. Mahley RW (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
17. Montine TJ, Huang DY, Valentine WM et al. (1996). Crosslinking of apolipoprotein E by products of lipid peroxidation. J Neuropathol Exp Neurol 55, 202-210.
18. Naiki H, Higuchi K, Hosokawa M and Takeda T (1989). Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal Biochem 177, 244-249.
19. Pinkus R, Weiner LM and Violet D (1996). Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione S-transferase gene expression. J Biol Chem 271, 13422-13429.
20. Poirier J (1994). Apolipoprotein E in animal models of brain injury and in Alzheimer's disease. Trends Neurosci 12, 525-530.
21. Ramos CL, Pou S and Rosen G (1995). Effect of anti-inflammatory drugs on myeloperoxidase-dependent hydroxyl radical generation by human neutrophils. Biochem Pharmacol 49, 1079-1084.
22. Rocca WA, Amaducci LA and Schoenberg BS (1986). Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 19, 415-424.
23. Roses AD, Saunders AM, Corder EH et al. (1995). Influence of the susceptibility genes apolipoprotein E-ε4 and apolipoprotein E-ε2 on the rate of disease expressivity of late-onset Alzheimer's disease. Drug Res 45, 413-417.
24. Saitoh T, Xia Y, Chen MD et al. (1995). The CYP2D6B mutant allele is overrepresented in the Lewy Body variant of Alzheimer's disease. Ann Neurol 37, 110-112.
25. Saunders AM, Strittmatter WJ, Schmechel D et al. (1993). Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
26. Schmechel DE, Saunders AM and Strittmatter WJ (1993). Increased amyloid β-peptide deposition in cerbral cortex as consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90, 9649-9653.
27. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B et al. (1995). Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem 41, 1068-1086.
28. Smith CD, Carney JM, Starke-Reed PE et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc Natl Acad Sci USA 88, 10540-10543.
29. Strittmatter WJ, Weisgraber KH, Huang DY et al. (1993). Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer's disease Proc Natl Acad Sci USA 90, 8098-8102.